Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ive never seen your "technical description.". What did you base it on? Are you purporting to have more expertise on this subject than Daniel Yazbeck?
Id refer you to the mydx white paper. Thats not my understanding of the facts. Where, exactly, are you getting your information?
If thats the case then why are you quoting numbers that are clearly unsupportable.
All early stage companies initially spend more than they bring in. Thats the definition of pre-cashflow-positive. Good signs in q1....operationally cash flow positive.
I dont know that a mydx ever showed such a result for a banana. I wouldnt assume a reason for such a result...I mean, are you sure that result was ever reached?
I understand what youre attempting to do, but unless someone tested a banana and returned 20% then its not necessary.
There is not 6+m dollars of debt.
IMO, we shouldnt waste energy explaining claims that we dont even know the source of. The sky is green. Dont come up with an explanation, question if any one actually claimed it, and what their motivation was.
Or so it seems to me.
Hopefully, but remember that this didnt start until late June so results wont be fully visible until the Q3 10q.
Where on earth did you get this information?? Link please.
Where did this banana result come from? Link please.
Where did you see this? Link please.
5:1 buys....and up 2.56%.
Nah, it's not being manipulated. Not at all.
Why doesn't that surprise me?
Another 2m share buy....2 minutes later, there's a $8.90 sell to bring it back down to .004. Nice.
Why LOL? It's not funny, it's something we've been dealing with for months. As soon as a large buy registers there's a corresponding (and almost immediate) sell to bring the current price back down to the bid.
Sometimes it's ridiculous. 100k shares bought at 10:54 to bring the price up to .0041. 65 seconds later someone sold 35 shares to bring the price back down to .0039. 35 shares at .0039 is 14 cents.
3.5:1 buys over sells
2m share purchase at 12:58.
Even so, only up 2.6%, and there's still a 2m share wall at .0041. Peculiar. No wonder people are skittish of buying this stock. What will it take to make it go up?
One of these days...sometime soon...it's going to run.
85% 5-star reviews on Amazon.
The other 15% were due to dead-on-arrival, and disappointment that the CannaDX wouldn't accurately analyze things that it wasn't built to analyze.
Sounds like it works pretty well to me.
No...perhaps in your opinion...but not "in fact."
Ok...no argument there. This is exhausting.
quote: Little Danny Yazbeck doesn't have a Ph.D. in ANYTHING. Whoever claimed that is totally false. He's an undergrad chemical engineering kid with a simple master's degree and nott even in instrumental analytical chemistry, which is the ONLY thing relevant for this non-working boolsheet gizmo.
Yeah....so, he has a PHD in Medicinal Chemistry. I'm going with what he says.
I..went..straight..to..the..source and asked Daniel Yazbeck. I explained that there seems to be some...confusion...about what chemicals are or are not evaluated.
It's all in the white paper, but the easy to read version (i.e. his response to my email) is here:
- We detect the Total Canna Profile (TCP) of each sample tested (which consists of Cannabinoids, Terpenes, Flavinoids, and any other chemical that might generate a sensor response on our proprietary 16 channel sensors)
- Each Strain typically generates a unique TCP (fingerprint) which consumers can then associate with a Feeling or Ailment Relief they experienced with that sample, and save it so they can track which chemical profile is working for them.
- Our Proprietary Algorithms are capable of interpreting this sensor response to predict a feeling or ailment relief based on crowdsourced data, as well as provide a prediction of the Cannabinoid and Terpene Values based on our Lab Tested Reference Database.
Read our White Paper for more details. https://www.cdxlife.com/mydx-white-paper/
- Also note we are the only handheld chemical tester that can test for Terpenes that I am aware of. There are other testers out there which cost upwards of $20-30K (Sage Analytics, Orange Photonics, QuantaCann, etc) that can test Cannabinoids only and claim to be more accurate that our device, but they are larger bench top machines and no one has ever definitively confirmed that for me via scientific proof their accuracy.
- We are very well positioned as an affordable primary screening device. If you want perfect accuracy, then you can spend $50K to buy a lab machine and hire a technician full time to run a test and hope to achieve that, or send it into a certified lab as of January 2018 and pay $400/test, assuming you can find a lab that can guarantee their accuracy.
I'm not one to make bold predictions, but I do agree that this stock should be trading at a much higher price than this.
The PPS crossed downward through this price last December when CEO Daniel Yazbeck openly acknowledged that the company was experiencing stock dilution. The PPS crossed back UP through this price in March, immediately following the announcement that the company had prevailed in a lawsuit to end the vast majority of the dilution. The subsequent Q1-17 10Q supported this announcement, showing only $13.5k of remaining convertible debt (down from a high of $309k on the Q3-16 10Q).
Since that time the news has gotten better and better. The PPS spiked to .022, but has since has lagged behind, moving sideways and ultimately downward as investors wait for the next piece of positive news. I believe the PPS will catch up with the current state of the company very soon.
If anyone is interested in a spreadsheet showing the last 6 quarters' financial results (transcribed directly from the 10Ks and 10Qs...easily verified) PM your email address to me. I don't have a messaging subscription so I can't reply directly to your PM, but will be happy to email the financial results.
Good luck to all.
You are trying to count the entire Liability side of the balance sheet as "debt." That's not correct. This is not a "shady and disingenuous accounting trick." The truth is that the VAST majority of that number is derivative liability, which is absolutely 100% not debt.
To rephrase your last sentence, counting derivative liability as a debt is a shady and disingenuous accounting trick.
Where did these numbers come from? Quote: There's a reason the vision prospective MYDX investors see isn't good -- $85k in revenue, a 10:1 cost of revenue ratio and $6.6m in debt is what keeps people away from investing in this company.
How's that $1,700,000 MYDX China deal coming along? Oh yeah, that's gone. POOF!
Look at that wall. 1.98m on the ask. Somebody doesn't want to risk a margin call over the weekend.
What would happen if everyone queued up a few bucks and placed a pile of buy orders at 3:58, with a limit of .0060? Might be fun to see.
I appreciate what you're saying. If there truly was $6.6m of debt then I think investors would be VERY interested. Fortunately that number is not accurate...only $79k in debt.
Quote: $85k in sales in Q1 2017 and being $6.6m in debt
in "total sales," that number was extrapolated in the K, but not in the Q
What do you see that is horrid about the fundamentals? Are they worse than other OTCs that you deal with?
Might be hard to know, since most OTCs don't even comply with SEC filing requirements. MYDX had an audited 10K.
You guys want to have some fun? Everybody pitch in a little and drive this price up past about .0062. There are over 7m short shares out there that have to cover at some point. Today could be the perfect storm.
Shares available to short went from 615k last night to 2.7m this morning. That means that somebody covered their positions. Might not be a bad idea for the rest of you shorts to do the same. You never know how much good news can come out over a long holiday weekend. Just sayin'.
By all accounts over 9m shares have been shorted in the past week or so. That's a lot of incentive to make sure that the price doesn't go up.
MYDX CEO Daniel Yazbeck has a MS..in..Medicinal..Chemistry, and has a long history of bringing new technologies to life for companies like Pfizer and Panasonic. I feel good about his credentials. I don't think someone with that pedigree would risk it all by rolling the dice on a fraudulent penny stock scheme.
The point of the device is not to recognize goofy strain names made up by guys growing in basements. The point of the device is to do away with the goofy names all together. This can be done by getting people to shop for chemical profiles instead of meaningless nicknames. That is the whole point of Yazbeck repeatedly showing people that two "blue dream" strains can have vastly different profiles. So, why care about the name at all? Instead, care only about the TCP. Yazbeck knows what he is talking about.
First, consumers need to be able to recognize the profiles they like versus the profiles they don't like, regardless of what the guy down the street is calling it.
I'm just repeating what they told me. I don't purport to be a scientist...I'm just relaying information. If you don't trust what they are telling you, then so be it.
The title of your link is "Characterizing the Smell of Marijuana by Odor Impact of Volatile Compounds..."
That's not what MYDX is trying to do.
Nobody is asking MYDX to "verify itself." Theirs is a complex scientific process and Daniel Yazbeck has many years of expertise. It's logical to ask them if statements made about their product are accurate or not. Why would we ask anyone else?
Shares available to short was sitting at 800,000 shares this morning. The normal number is around 10,000,000. That means that somebody has 9.2m shares of MYDX shorted, and they don't want the price to go up.
Would love to see someone come in and squeeze them out.
Good timing DiamondDak. I saw the claim and wondered about its validity, too. I reached out to CDX and received the following response (along with a link to the white paper):
We detect the Total Canna Profile (TCP) of each sample tested (which consists of Cannabinoids, Terpenes, Flavinoids, and any other chemical that might generate a sensor response on our proprietary 16 channel sensors)
IMPORTANT TO KEEP IN MIND... Yesterday there was a credible report of a long term investor who had seen enough, and put in an order to sell his entire position (5.75m shares). He reported that the order was completely filled over the course of the day.
Result: yesterday saw a 6:7 buy:sell ratio (and a 10.6% pps decrease...which seems extreme IMO). If the 5.75m sell hadn't been placed the ratio would have been 3:2 in favor of buys. That could have moved us from .0056 to .006+.